{"id":"https://openalex.org/W2482995692","doi":"https://doi.org/10.1158/1538-7445.am2016-4779","title":"Abstract 4779: In silico design, synthesis and evaluation of a new family of C1-substituted pyrrolobenzodiazepines (PBDs)","display_name":"Abstract 4779: In silico design, synthesis and evaluation of a new family of C1-substituted pyrrolobenzodiazepines (PBDs)","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2482995692","doi":"https://doi.org/10.1158/1538-7445.am2016-4779","mag":"2482995692"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-4779","doi":"https://doi.org/10.1158/1538-7445.am2016-4779","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-4779","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2482995692"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103413662","display_name":"Paul J. Jackson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J. M. Jackson","raw_affiliation_strings":["Femtogenix, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Femtogenix, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009358647","display_name":"George Procopiou","orcid":"https://orcid.org/0000-0001-9429-0050","observed_orcids":["https://orcid.org/0000-0001-9429-0050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Procopiou","raw_affiliation_strings":["Femtogenix, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Femtogenix, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059307227","display_name":"Nicolas Veillard","orcid":"https://orcid.org/0009-0002-7536-2519","observed_orcids":["https://orcid.org/0009-0002-7536-2519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicolas Veillard","raw_affiliation_strings":["Femtogenix, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Femtogenix, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066057391","display_name":"Julia Mantaj","orcid":"https://orcid.org/0000-0002-1155-5664","observed_orcids":["https://orcid.org/0000-0002-1155-5664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Mantaj","raw_affiliation_strings":["Femtogenix, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Femtogenix, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006583391","display_name":"Khondaker Miraz Rahman","orcid":"https://orcid.org/0000-0001-8566-8648","observed_orcids":["https://orcid.org/0000-0001-8566-8648"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Miraz Rahman","raw_affiliation_strings":["Femtogenix, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Femtogenix, London, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015974843","display_name":"David E. Thurston","orcid":"https://orcid.org/0000-0001-8032-7203","observed_orcids":["https://orcid.org/0000-0001-8032-7203","https://orcid.org/0000-0001-7845-0704"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David E. Thurston","raw_affiliation_strings":["Femtogenix, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Femtogenix, London, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"4779","last_page":"4779"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyrrolobenzodiazepine","display_name":"pyrrolobenzodiazepine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dna-minor-groove-binding","display_name":"DNA minor groove binding","score":0.796999990940094},{"id":"https://openalex.org/keywords/dna-cross-linking","display_name":"DNA cross-linking","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7450000047683716},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7570000290870667},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/binding-free-energy","display_name":"binding free energy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/dna-distortion","display_name":"DNA distortion","score":0.5009999871253967},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.659853458404541},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.6439951062202454},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6146345734596252},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.6071917414665222},{"id":"https://openalex.org/C180577832","wikidata":"https://www.wikidata.org/wiki/Q127920","display_name":"Covalent bond","level":2,"score":0.49859189987182617},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4959205090999603},{"id":"https://openalex.org/C108204754","wikidata":"https://www.wikidata.org/wiki/Q353392","display_name":"Adduct","level":2,"score":0.4957207441329956},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3801376223564148},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27138572931289673},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.21102389693260193},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-4779","doi":"https://doi.org/10.1158/1538-7445.am2016-4779","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-4779","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.428600013256073,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2563611173","https://openalex.org/W4406097399","https://openalex.org/W2961257847","https://openalex.org/W3174378476","https://openalex.org/W2506288005","https://openalex.org/W3011121377","https://openalex.org/W2008555526","https://openalex.org/W2325761168","https://openalex.org/W2020619239","https://openalex.org/W1984742692"],"abstract_inverted_index":{"Abstract":[0],"The":[1,88],"pyrrolobenzodiazepines":[2,483],"(PBDs)":[3],"are":[4,46,83,132,428],"a":[5,79,98,147,154,170,193,223,306,328,343,478],"class":[6],"of":[7,23,36,48,81,90,115,149,161,172,186,292,300,346,385,436,477,481,488,493],"naturally":[8],"occurring":[9],"and":[10,25,30,44,78,103,136,252,351,370,441,475],"synthetic":[11],"DNA":[12,134,188,198,229,315,364,387],"minor-groove":[13],"binding":[14,293,308,331],"agents.":[15],"They":[16],"covalently":[17],"bind":[18],"to":[19,74,100,109,124,152,168,197,214,243,271,383,388,431,438,442],"the":[20,34,37,55,91,118,157,184,187,203,216,244,264,282,298,314,368,386,404,414,434,489,494],"C2-amino":[21],"group":[22],"guanines,":[24],"can":[26,40],"form":[27,272],"mono-alkylated":[28],"adducts":[29,390],"cross-links":[31],"depending":[32],"on":[33,281,337,367],"structure":[35,93],"molecule.":[38],"PBDs":[39,437],"be":[41],"extremely":[42],"cytotoxic,":[43],"there":[45],"reports":[47,126],"IC50":[49,411],"values":[50,412],"in":[51,54,68,85,117,210,239,267,289,297,340,395,398,413,451],"cell":[52,399],"lines":[53,400],"high":[56],"femtomolar":[57],"ranges.":[58],"Synthetic":[59],"A-ring-linked":[60],"PBD":[61,92,106,130,163],"dimers":[62,131],"have":[63,121],"found":[64],"use":[65,450],"as":[66,97,402,446],"payloads":[67,448],"antibody":[69],"drug":[70],"conjugates":[71],"(ADCs)":[72],"due":[73,123],"their":[75,179,444],"potent":[76],"cytoxicity,":[77],"number":[80,171],"ADCs":[82],"now":[84,429],"clinical":[86],"trials.":[87],"C-ring":[89,119],"has":[94],"been":[95,122],"under-exploited":[96],"means":[99],"improve":[101],"cytotoxicity,":[102,440],"for":[104,156,424,449,497],"joining":[105],"units":[107],"together":[108],"create":[110],"novel":[111,447],"dimers.":[112,164],"This":[113,286],"lack":[114],"interest":[116],"may":[120],"literature":[125],"that":[127,234,355,377],"related":[128],"C2-linked":[129,162,302],"poorly":[133],"interactive":[135],"cytotoxic.":[137],"Using":[138],"our":[139,250],"proprietary":[140],"molecular":[141],"dynamics":[142],"(MD)":[143],"protocols,":[144],"we":[145],"undertook":[146],"series":[148],"MD":[150],"simulations":[151,253],"establish":[153],"rationale":[155],"poor":[158],"DNA-binding":[159,359],"affinity":[160,309,332],"We":[165],"were":[166,407],"able":[167],"determine":[169],"characteristics":[173],"preventing":[174],"efficient":[175],"DNA-interaction":[176],"including":[177],"(a)":[178],"shape":[180],"does":[181],"not":[182,208],"follow":[183],"curvature":[185],"minor":[189,265,283],"groove,":[190],"(b)":[191],"if":[192,222],"molecule":[194],"is":[195,207,226,231],"attached":[196],"via":[199],"one":[200,301,425],"imine":[201,205],"moiety,":[202],"other":[204],"moiety":[206],"oriented":[209],"an":[211,268,323],"appropriate":[212,269],"position":[213],"effect":[215],"second":[217],"covalent":[218,257,389],"cross-linking":[219],"event,":[220],"(c)":[221],"cross-linked":[224],"model":[225],"produced,":[227],"significant":[228,358],"distortion":[230],"observed,":[232],"suggesting":[233],"rapid":[235],"repair":[236],"would":[237],"occur":[238],"cells,":[240],"perhaps":[241],"contributing":[242],"low":[245],"cytotoxicity.":[246],"During":[247],"this":[248],"study,":[249],"models":[251],"suggested":[254,305],"that,":[255],"after":[256,420],"adduct":[258],"formation,":[259],"C1-substituents":[260],"should":[261],"extend":[262],"along":[263],"groove":[266,284],"orientation":[270],"extensive":[273],"van":[274],"der":[275],"Waals":[276],"interactions":[277],"with":[278,313,410],"functional":[279],"groups":[280],"floor.":[285],"was":[287,349],"reflected":[288],"free":[290],"energy":[291],"calculations.":[294],"For":[295],"example,":[296],"case":[299],"dimer,":[303],"calculations":[304],"weak":[307],"(i.e.,":[310,333],"-42.74":[311],"kcal/mol)":[312],"sequence":[316],"5\u2019-GCGATACTCGC-3\u2019,":[317],"whereas":[318],"under":[319],"identical":[320],"experimental":[321],"conditions,":[322],"equivalent":[324],"C1-linked":[325],"dimer":[326],"had":[327],"much":[329],"higher":[330],"-50.42":[334],"kcal/mol).":[335],"Based":[336],"these":[338],"promising":[339],"silico":[341,472],"data,":[342],"small":[344],"library":[345,379],"C1-PBD":[347],"molecules":[348,406],"synthesised,":[350],"biophysical":[352],"results":[353],"indicated":[354],"they":[356],"possessed":[357],"affinity.":[360],"HPLC-MS":[361],"experiments":[362,397],"using":[363],"sequences":[365,375],"based":[366],"STAT3":[369],"NF-\u00caB":[371],"transcription":[372],"factor":[373],"consensus":[374],"showed":[376],"some":[378],"members":[380],"converted":[381],"up":[382],"60%":[384],"within":[391],"3":[392],"hours.":[393],"Furthermore,":[394],"preliminary":[396],"such":[401],"MDA-MB231,":[403],"same":[405],"highly":[408],"cytotoxic":[409],"nanomolar":[415],"region":[416],"(e.g.,":[417],"36":[418],"nM":[419],"72":[421],"hour":[422],"incubation":[423],"compound).":[426],"Studies":[427],"underway":[430],"further":[432],"functionalise":[433],"C1-position":[435],"enhance":[439],"assess":[443],"viability":[445],"ADCs.":[452],"Citation":[453],"Format:":[454],"Paul":[455],"J.":[456],"M.":[457],"Jackson,":[458],"George":[459],"Procopiou,":[460],"Nicolas":[461],"Veillard,":[462],"Julia":[463],"Mantaj,":[464],"K":[465],"Miraz":[466],"Rahman,":[467],"David":[468],"E.":[469],"Thurston.":[470],"In":[471],"design,":[473],"synthesis":[474],"evaluation":[476],"new":[479],"family":[480],"C1-substituted":[482],"(PBDs).":[484],"[abstract].":[485],"In:":[486],"Proceedings":[487],"107th":[490],"Annual":[491],"Meeting":[492],"American":[495],"Association":[496],"Cancer":[498,509],"Research;":[499],"2016":[500],"Apr":[501],"16-20;":[502],"New":[503],"Orleans,":[504],"LA.":[505],"Philadelphia":[506],"(PA):":[507],"AACR;":[508],"Res":[510],"2016;76(14":[511],"Suppl):Abstract":[512],"nr":[513],"4779.":[514]},"counts_by_year":[{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-08-23T00:00:00"}